Orbimed

About This Fund

Orbimed is an institutional investor (Healthcare Startups,) founded in 1989 and headquartered in New York City, New York, United States (and 6 other locations). OrbiMed is a global healthcare investment firm founded in 1989. The firm invests across the global healthcare industry from seed-stage venture capital to large publicly-traded companies through three strategies: Private Equity, Private Credit/Royalty, and Public Equity. Notable achievements: 90 new healthcare therapies developed and brought to patients, $3B+ committed to developing-country healthcare, 110+ life sciences start-ups backed. Offices in New York, San Francisco, Shanghai, Herzliya, Hong Kong, and London. Venture capital fund focused on investing in healthcare industry. Invests in companies engaged in the discovery and development of biopharmaceutical products, medical technologies, medical devices, diagnostics, drug discovery tools, and healthcare information technology and services companies. Fund Philosophy: OrbiMed is a global investment firm that invests in companies engaged in the discovery and development of biopharmaceutical products, medical technologies, medical devices, diagnostics, drug discovery tools, and healthcare information technology and services companies. The firm believes the healthcare industry's powerful growth profile coupled with its magnitude and complexity create myriad investment opportunities. Practice areas include Investment Industry. The firm operates as Venture Capital Funds and Private Equity Funds. Key investment sectors include Healthcare / HealthTech and Biotech / Biopharma. Assets Under Management (AUM): $20 billion.

Investment Focus